Interested in mechanisms of resistance to androgen deprivation therapy in #ProstateCancer? 🤔
This review summarizes the mechanisms, biomarkers, and emerging therapies for treatment-resistant prostate cancer driven by androgen receptor signaling.
Learn more: https://t.co/0CcJq7wZCP
🔬🍾 New publication! Happy to see part of my PhD work now published in Cell Death & Disease (@SpringerNature).
I am very grateful to everyone involved in making this happen.
👇👇
https://t.co/GGIY4JCUgh
Here we show that androgens suppress TXNIP, which acts as a tumor suppressor in prostate cancer by regulating the cell cycle and glucose metabolism. As a result, TXNIP loss during androgen-deprivation therapy promotes tumor resistance 💊.
https://t.co/GGIY4JCUgh
After several intense and exciting years, I’ve finally defended my PhD! 🧬🎓 Huge thanks to my lab mates, my supervisors, family and friends for their support, and to the committee for their feedback and for making this day so special!! 🍾🍾 @bioxgroup
Happy to share our refined manuscript focusing on improvement and #singlecell analysis of #prostatecancer patient-derived #organoids just published in @CellReports:
https://t.co/IL1eRbUvHP
Big congrats to our PhD student @RobinDolgos for his first 1st author paper 👏🏻🧫💊🔬🧬
#DíadelNiñoconCáncer Ayer Isa recibió la ayuda de la @asoc_galban. No podemos estar mas agradecidos ni comprometidos con este proyecto. Aportar conocimiento en un problema tan devastador como es una enfermedad infantil no puede motivarnos más Gracias!!! @SCTAsturias@uniovi_info
Super happy and proud to be presenting at #ASEICACongress two of our research lines regarding TXNIP's control of metabolism of cancer cells and in the tumor microenvironment rearrangement associated with the development of hormone-resistance in prostate cancer 😄🔬 @bioxgroup